Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment

PURPOSE: Hypertension is a mechanism-based toxicity of sorafenib and other cancer therapeutics that inhibit the vascular endothelial growth factor (VEGF) signaling pathway (VSP). This prospective, single center, cohort study characterized ambulatory blood pressure (BP) monitoring (ABPM) as an early...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Maitland, Michael L., Kasza, Kristen E., Karrison, Theodore, Moshier, Kristin, Sit, Laura, Black, Henry R., Undevia, Samir D., Stadler, Walter M., Elliott, William J., Ratain, Mark J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2756980/
https://ncbi.nlm.nih.gov/pubmed/19773379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-0058
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky